Dr. Lal Path Labs Fair Value
Dr. Lal Path Labs (LALPATHLAB) average fair value is ₹293.59 across 8 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹1617.2 (-81.85%), fair value range ₹91.53–₹794.04. For live price and a broader fundamental view, visit Dr. Lal Path Labs screener.
Fair Value Analysis Export
LALPATHLAB Fair Value vs Current Price — Valuation Summary
LALPATHLAB average fair value, fair value range, price gap and valuation status across 8 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF). Examine LALPATHLAB earnings report for recent quarterly revenue, profit and EPS trends.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Earnings Growth Model (PEG)
Peter Lynch Fair Value
Benjamin Graham Number
Discounted Cash Flow (DCF)
LALPATHLAB Fair Value Analysis — Data Sources & Coverage
Dr. Lal Path Labs financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. See LALPATHLAB book value to compare market price against book value per share.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
LALPATHLAB vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Dr. Lal Path Labs P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| One Global Service Provi… | ONEGLOBAL | 14.84 | 9.12 | ₹920 |
| Suraksha Diagnostic | SURAKSHA | 40.64 | 5.71 | ₹1,356 |
| Gujarat Kidney and Super… | GKSL | 83.28 | 3.9 | ₹1,117 |
| Invicta Diagnostic | INVICTA | 17.24 | 1.68 | ₹80 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.